SYN-004 (ribaxamase) prevents New Onset Clostridium difficile Infection by Protecting the Integrity Gut Microbiome in a Phase 2b Study
SYN-004(ribaxamase)通过保护肠道微生物群的完整性,在一项 2b 期研究中预防了新发艰难梭菌感染。
期刊:Investigative Ophthalmology & Visual Science
影响因子:4.7
doi:10.1167/iovs.61.8.22
Zhao, Fuxin; Zhang, Dake; Ge, Chaoxiang; Zhang, Lei; Reinach, Peter S; Tian, Xiangjun; Tao, Chengcheng; Zhao, Zhelin; Zhao, Chenchen; Fu, Wenjie; Zeng, Changqing; Chen, Wei; Porter, Nada; Brewer, Lawrence; Anderson, Katie; Hoffman, Jessie; Thibault, Julien; Gant, John; Frazier, Hilaree; Ghower, Adam; Kraner, Susan; Landfield, Philip; Blalock, Eric; Thibault, Olivier; Kokai-Kun, John; Roberts, Tracey; Coughlin, Olivia; Whalen, Heidi; Le, Charles; Da Costa, Christopher; Sliman, Joseph